Ascendis Pharma's growth hormone formally approved in the EU
On Thursday, the European Commission has officially approved Ascendis Transcon hGH, which was given a positive recommendation from the European Medicines Agency.
by MIKKEL AABENHUS HEMMINGSEN, translated by daniel pedersen
Following a positive recommendation from the European Medicines Agency (EMA), the European Commission has officially approved Ascendis Pharma's Lonapegsomatropin, Ascendis announces in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ascendis Pharma extends trial of growth hormone in adults
For subscribers
